rs71473272

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_001368067.1(LDB3):​c.546T>C​(p.Ser182Ser) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00444 in 1,613,964 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0035 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0045 ( 44 hom. )

Consequence

LDB3
NM_001368067.1 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00001666
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:13

Conservation

PhyloP100: -0.424

Publications

2 publications found
Variant links:
Genes affected
LDB3 (HGNC:15710): (LIM domain binding 3) This gene encodes a PDZ domain-containing protein. PDZ motifs are modular protein-protein interaction domains consisting of 80-120 amino acid residues. PDZ domain-containing proteins interact with each other in cytoskeletal assembly or with other proteins involved in targeting and clustering of membrane proteins. The protein encoded by this gene interacts with alpha-actinin-2 through its N-terminal PDZ domain and with protein kinase C via its C-terminal LIM domains. The LIM domain is a cysteine-rich motif defined by 50-60 amino acids containing two zinc-binding modules. This protein also interacts with all three members of the myozenin family. Mutations in this gene have been associated with myofibrillar myopathy and dilated cardiomyopathy. Alternatively spliced transcript variants encoding different isoforms have been identified; all isoforms have N-terminal PDZ domains while only longer isoforms (1, 2 and 5) have C-terminal LIM domains. [provided by RefSeq, Jan 2010]
LDB3 Gene-Disease associations (from GenCC):
  • myofibrillar myopathy 4
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • familial dilated cardiomyopathy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 10-86687270-T-C is Benign according to our data. Variant chr10-86687270-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 43880.
BP7
Synonymous conserved (PhyloP=-0.424 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00352 (536/152202) while in subpopulation SAS AF = 0.0108 (52/4826). AF 95% confidence interval is 0.00844. There are 1 homozygotes in GnomAd4. There are 278 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 44 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LDB3NM_001368067.1 linkc.546T>C p.Ser182Ser splice_region_variant, synonymous_variant Exon 6 of 9 ENST00000263066.11 NP_001354996.1
LDB3NM_007078.3 linkc.690-4626T>C intron_variant Intron 5 of 13 ENST00000361373.9 NP_009009.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LDB3ENST00000263066.11 linkc.546T>C p.Ser182Ser splice_region_variant, synonymous_variant Exon 6 of 9 1 NM_001368067.1 ENSP00000263066.7
LDB3ENST00000361373.9 linkc.690-4626T>C intron_variant Intron 5 of 13 1 NM_007078.3 ENSP00000355296.3
ENSG00000289258ENST00000443292.2 linkc.2199-4626T>C intron_variant Intron 15 of 17 1 ENSP00000393132.2

Frequencies

GnomAD3 genomes
AF:
0.00352
AC:
535
AN:
152084
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.0156
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0106
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00456
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00503
AC:
1253
AN:
249284
AF XY:
0.00589
show subpopulations
Gnomad AFR exome
AF:
0.000581
Gnomad AMR exome
AF:
0.00359
Gnomad ASJ exome
AF:
0.0148
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00484
Gnomad OTH exome
AF:
0.00677
GnomAD4 exome
AF:
0.00453
AC:
6627
AN:
1461762
Hom.:
44
Cov.:
33
AF XY:
0.00489
AC XY:
3559
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33480
American (AMR)
AF:
0.00407
AC:
182
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
354
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0122
AC:
1050
AN:
86256
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53368
Middle Eastern (MID)
AF:
0.0146
AC:
84
AN:
5764
European-Non Finnish (NFE)
AF:
0.00414
AC:
4606
AN:
1111940
Other (OTH)
AF:
0.00535
AC:
323
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
389
778
1168
1557
1946
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00352
AC:
536
AN:
152202
Hom.:
1
Cov.:
33
AF XY:
0.00374
AC XY:
278
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41522
American (AMR)
AF:
0.00471
AC:
72
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0156
AC:
54
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.0108
AC:
52
AN:
4826
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10608
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00456
AC:
310
AN:
67988
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
29
59
88
118
147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00393
Hom.:
0
Bravo
AF:
0.00345
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:13
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 09, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ser182Ser in exon 6 of LDB3: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and has been identified in 0.3% (22/6920) of European American chromosomes from a broad population by th e NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs714 73272). Ser182Ser in exon 6 of LDB3 (rs71473272; allele frequency = 0.3%, 22/69 20) ** -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:5
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LDB3: BP4, BP7, BS1, BS2 -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Myofibrillar myopathy 4 Uncertain:1Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myofibrillar Myopathy, Dominant Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dilated Cardiomyopathy, Dominant Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Left ventricular noncompaction cardiomyopathy Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dilated cardiomyopathy 1C Benign:1
Jan 30, 2015
Cytogenetics- Mohapatra Lab, Banaras Hindu University
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Cardiovascular phenotype Benign:1
Jul 31, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
11
DANN
Benign
0.59
PhyloP100
-0.42
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000017
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71473272; hg19: chr10-88447027; COSMIC: COSV107309439; API